ArticleThe international journal of biochemistry & cell biology2013

Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.

Manjula Nakka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.